A Paltry 1 to 5 Vials Per Day of Aduhelm are Ordered Across Thousands of U.S. Hospitals, Says Purchasing Group

Sales of Biogen’s controversial Alzheimer’s drug Aduhelm (aducanumab) have been exceedingly low.
Source: Drug Industry Daily